Skip to main content
Celltrion, Inc. logo

Celltrion, Inc. — Investor Relations & Filings

Ticker · 068270 ISIN · KR7068270008 LEI · 988400JFZG785WJX3D68 KO Manufacturing
Open in API
Filings indexed 1,282 across all filing types
Latest filing 2026-01-30 Director's Dealing
Country KR South Korea
Listing KO 068270

About Celltrion, Inc.

https://www.celltrion.com/

Celltrion, Inc. is a biopharmaceutical company that provides integrated solutions across the entire value chain, from research and development to clinical trials, regulatory affairs, and large-scale manufacturing. The company specializes in developing and producing innovative therapeutics, including biosimilars and novel biopharmaceuticals. Its portfolio primarily targets autoimmune diseases and oncology. Celltrion is recognized for launching the world's first monoclonal antibody biosimilar. A key product is ZYMFENTRA® (infliximab-dyyb), a subcutaneous formulation for the maintenance treatment of moderately-to-severely active Crohn's disease and ulcerative colitis. The company also develops and manufactures chemical pharmaceuticals.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the share ownership and changes in holdings (specifically stock options exercised) by an executive (Lee Eung-seop) of Celltrion. This type of filing is classified as a 'Director's Dealing' (DIRS) as it reports personal share transactions and ownership changes by company insiders.
2026-01-30 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Celltrion regarding the 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). It details the disposal of treasury shares due to the exercise of stock options by employees. According to the filing definitions, 'Transaction in Own Shares' (POS) covers reports of the company buying back or selling its own shares (share repurchase/issuance). Since this document specifically details the disposal of treasury shares, it falls under the POS category.
2026-01-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (증권선물위원회) and the Korea Exchange. It details the sale of shares by an executive (Lee Eung-seop) of Celltrion. This is a standard regulatory filing for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2026-01-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS). This type of filing is a mandatory disclosure for insiders (directors, executives, and major shareholders) regarding their transactions in the company's stock. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider trading and share ownership changes by company insiders.
2026-01-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the shareholding status of the company's largest shareholder (Celltrion Holdings) and its special related parties, including changes in share ownership, purpose of holding (management influence), and specific details of the shareholders. This fits the definition of a Major Shareholding Notification (MRQ).
2026-01-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 98% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. It details the acquisition of shares by Celltrion Holdings, a major shareholder of Celltrion. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) or 'Major Shareholding Notification' (MRQ) depending on the context. Given the focus on the major shareholder's change in ownership stake, it aligns best with the Major Shareholding Notification category.
2026-01-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.